Home > Healthcare > Medical Devices > Diagnostic Devices > helicobacter pylori testing market
Get a free sample of Helicobacter Pylori Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Helicobacter Pylori Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Significant technological developments in testing landscape are offering favourable opportunities for market growth.
North America helicobacter pylori testing industry will record 4.3% CAGR through 2032, propelled by the region's advanced healthcare infrastructure, high prevalence of gastrointestinal disorders, and significant investments in medical research and diagnostics.
Helicobacter pylori testing market from the diagnostic laboratories segment will reach USD 390.9 million by 2032, primarily due to their comprehensive testing capabilities and advanced diagnostic technologies.
Helicobacter pylori testing industry size was USD 483 million in 2023 and will grow at 6.8% CAGR between 2024 and 2032, driven by the increasing prevalence of H. pylori infections and advancements in diagnostic technologies.
Some of the prominent helicobacter pylori testing industry players are Abbott Laboratories, Advance Pharma, Avanos Corporate, Bio-Rad Laboratories, Inc., Cardinal Health, Inc., Epitope Diagnostics, Gulf Coast Scientific, Laboratory Corporation of America, Inc., Medline Industries, Meridian Biosciences, Inc., and Quidel Corporation, among others.